SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Hamilton who wrote (429)6/1/2000 11:23:00 PM
From: Mindshare  Read Replies (1) of 500
 
Hi Dan.....

Thought I would weigh in with my two cents. Novacor device has a bad history of clotting. I'm pretty sure FDA mandated special labeling about clotting for the device. I think the value here is the distribution channel. Second only to TCA (Heartmate). It does show a commitment by Bryden for the long term. If they can just get clinical trials kicked off, everything will be fine. Patience is your ally here. If they don't get clinicals going in the next year (June 2001) there is something wrong that they are not making public IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext